Catherine Prescott

Over 20 years of experience in research, management and business in the biotechnology, pharmaceutical and venture capital sectors.

Founder/Director Biolatris Ltd that provides due-diligence services to support decisions relating to investment and options to leverage the potential commercial value of intellectual property. Non-executive Director Videregen Ltd a regenerative medicine company developing organ replacement products to address the chronic shortage of organs for transplantation; advisory board member Trakcel Ltd that is developing innovative supply chain management software for cell therapeutics; mentor to Vietnam Silicon Valley a government focussed initiative to support start-ups and a Member of the Board of Trustees IMET2000 a charity that aims to promote inexpensive, continuous and accessible healthcare education and training for all professionals working in the global health sector. Cathy also founded the ‘Quartet’, a consortium of senior representatives of the reinsurance and pensions advisory services researching the potential impact of regenerative medicines and emerging technologies on the financial services sector.

Mentor to the Ignite Summer Business School programme (Centre for Entrepreneurial Learning, Cambridge University), Senior Associate for the Masters in Bioscience Enterprise (Cambridge University) and Visiting Professor at Kings College, London. Co-editor and contributor ‘The Delivery of Regenerative Medicines and Impact on Healthcare’ (CRC Press).

Formerly Cathy chaired the UK National Stem Cell Network Advisory committee, was a Life Sciences Board member WPI (MA US) and Director of the East of England Stem Cell Network.